Patel Anish sold ELVN
December 29, 2023 · Form 4 insider transaction
Patel Anish sold 20 shares of Enliven Therapeutics, Inc. at $15.00 per share, a transaction worth $300.00. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
20
Price
$15.00
Total value
$300.00
InsiderPatel Anish
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 29, 2023
Filing dateJanuary 2, 2024
Shares owned after33,097
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.